Active Ingredient History
A blood cell, also called a hematopoietic cell, hemocyte, or hematocyte, is a cell produced through hematopoiesis and found mainly in the blood. Major types of blood cells include red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes). Together, these three kinds of blood cells add up to a total 45% of the blood tissue by volume, with the remaining 55% of the volume composed of plasma, the liquid component of blood. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acne Vulgaris (Phase 2)
Amyloidosis (Phase 3)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Anemia, Diamond-Blackfan (Phase 2)
Anemia, Refractory (Phase 2)
Antigens, CD20 (Phase 1)
Antiphospholipid Syndrome (Phase 1)
Arthritis, Rheumatoid (Phase 1)
Autoimmune Diseases (Phase 2)
beta-Thalassemia (Phase 1/Phase 2)
Bone Marrow Cells (Phase 2)
Bone Marrow Failure Disorders (Phase 2)
Brain Neoplasms (Phase 3)
Breast Neoplasms (Phase 3)
Breast Neoplasms, Male (Phase 2)
Bronchopulmonary Dysplasia (Phase 1)
Burkitt Lymphoma (Phase 3)
Carcinoma (Phase 2)
Cardiomyopathies (Phase 1/Phase 2)
Cartilage Diseases (Phase 2)
Central Nervous System Neoplasms (Phase 3)
Cerebellar Ataxia (Phase 2)
Cerebellar Diseases (Phase 2)
Cerebral Palsy (Phase 2)
Chordoma (Phase 1)
Chromosome Aberrations (Phase 2)
Chronic Disease (Phase 2)
Colonic Neoplasms (Phase 1)
Colorectal Neoplasms (Phase 1/Phase 2)
Coronary Artery Bypass (Phase 1/Phase 2)
Crohn Disease (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Diffuse Intrinsic Pontine Glioma (Phase 1)
Diploidy (Phase 2)
Encephalitis (Phase 2)
Endocrine System Diseases (Phase 1/Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Fanconi Anemia (Phase 2)
Glioblastoma (Phase 2/Phase 3)
Glioma (Phase 1)
Gliosarcoma (Phase 1/Phase 2)
Glucose Metabolism Disorders (Phase 1/Phase 2)
Graft vs Host Disease (Phase 3)
Granulomatous Disease, Chronic (Phase 1/Phase 2)
Hamartoma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Hematologic Diseases (Phase 2)
Hematologic Neoplasms (Phase 1)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hemoglobinuria, Paroxysmal (Phase 2)
HIV Infections (Phase 2)
Hodgkin Disease (Phase 3)
Immune System Diseases (Phase 1/Phase 2)
Infections (Phase 2)
Infertility, Male (Phase 1/Phase 2)
Inflammatory Breast Neoplasms (Phase 2)
Intestinal Neoplasms (Phase 2)
Intraocular Lymphoma (Phase 2)
Kidney Neoplasms (Phase 2)
Lambert-Eaton Myasthenic Syndrome (Phase 2)
Leukemia (Phase 3)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Eosinophilic, Acute (Phase 3)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Large Granular Lymphocytic (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 2/Phase 3)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Mast-Cell (Phase 2)
Leukemia, Monocytic, Acute (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 4)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Acute (Phase 3)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Neutrophilic, Chronic (Phase 2)
Leukemia, Plasma Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 3)
Leukemia, Prolymphocytic, B-Cell (Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 3)
Liver Neoplasms (Phase 1)
Lung Neoplasms (Phase 3)
Lupus Erythematosus, Systemic (Phase 2/Phase 3)
Lymphoma (Phase 3)
Lymphoma, AIDS-Related (Phase 1)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 2)
Lymphoproliferative Disorders (Phase 2)
Mastocytosis (Phase 2)
Mediastinal Neoplasms (Phase 3)
Medulloblastoma (Phase 3)
Melanoma (Phase 2)
Meningitis (Phase 1/Phase 2)
Metabolic Diseases (Phase 1/Phase 2)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Myasthenia Gravis (Phase 2)
Myelodysplastic Syndromes (Phase 4)
Myeloproliferative Disorders (Phase 3)
Myocardial Infarction (Phase 2/Phase 3)
Neoplasm Metastasis (Phase 2/Phase 3)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neuroblastoma (Phase 3)
Neuroectodermal Tumors (Phase 3)
Neuromyelitis Optica (Phase 2)
Neutropenia (Phase 3)
Opsoclonus-Myoclonus Syndrome (Phase 2)
Organ Transplantation (Phase 2)
Osteoarthritis, Hip (Phase 1)
Osteoarthritis, Knee (Phase 1)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 1/Phase 2)
Pemphigus (Phase 1)
Peripheral Vascular Diseases (Phase 1)
Plasmablastic Lymphoma (Phase 1/Phase 2)
Plasmacytoma (Phase 2)
Polycythemia Vera (Phase 2)
Precancerous Conditions (Phase 2)
Primary Myelofibrosis (Phase 3)
Prognosis (Phase 2)
Prostatic Neoplasms (Phase 2)
Retinitis Pigmentosa (Phase 1/Phase 2)
Retinoblastoma (Phase 3)
Rhabdoid Tumor (Phase 3)
Rhabdomyosarcoma (Phase 2)
Sarcoidosis (Phase 1/Phase 2)
Sarcoma (Phase 3)
Sarcoma, Ewing (Phase 2)
Sarcoma, Myeloid (Phase 2)
Scleroderma, Systemic (Phase 3)
Severe Combined Immunodeficiency (Phase 2)
Sezary Syndrome (Phase 2)
Shwachman-Diamond Syndrome (Phase 2)
Smoldering Multiple Myeloma (Phase 3)
Spinal Cord Injuries (Phase 1/Phase 2)
Stem Cell Transplantation (Phase 2)
Stiff-Person Syndrome (Phase 2)
Stroke (Phase 1)
Teratoma (Phase 2)
Testicular Neoplasms (Phase 3)
Thrombocythemia, Essential (Phase 2)
Thrombocytopenia (Phase 2)
Tissue Donors (Phase 2)
Translocation, Genetic (Phase 2)
Transplantation (Phase 2)
Transplantation, Autologous (Phase 2)
Transplantation, Homologous (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Vaginal Neoplasms (Phase 2)
Vasculitis, Central Nervous System (Phase 2)
Waldenstrom Macroglobulinemia (Phase 3)
Wiskott-Aldrich Syndrome (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
